Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart

Magnetic Resonance in Medicine

Volumn 60, Issue 1, 2008, Pages 82-89

  Wood, John C ^a,c   Aguilar, Michelle ^a   Otto Duessel, Maya ^a   Nick, Hanspeter ^b   Nelson, Marvin D ^a   Moats, Rex ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Mailstop 34   (United States)

Author keywords

Iron chelation; R1 and R2; Transverse relaxation

Indexed keywords

AMINES; ANIMALS; CALIBRATION; CHELATION; IRON; PHYSIOLOGY; UNLOADING;

CALIBRATION CURVES; IRON CHELATION; IRON CHELATORS; IRON CONCENTRATIONS; IRON DISTRIBUTION; R1 AND R2; TRANSVERSE RELAXATION; TRANSVERSE RELAXATION RATE;

LOADING;

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; IRON CHELATING AGENT; IRON DEXTRAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DOSE CALCULATION; DOSE TIME EFFECT RELATION; FEMALE; GERBIL; HEART MUSCLE METABOLISM; IRON CHELATION; LIVER METABOLISM; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAXATION TIME; SINGLE DRUG DOSE; TISSUE DISTRIBUTION;

EID: 46849092816     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21660     Document Type: Article

References (28)

1. McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci 1983;19:205-266.
2. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
3. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002;360:516-520.
4. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Malcolm Walker J, Pennell DJ. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355.
5. Wood JC, Tyszka JM, Ghugre N, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle-cell disease. Blood 2004;103:1934-1936.
6. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-1465.
7. St Pierre TG, Clark PR, Chua-Anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861.
8. Ghugre NR, Coates TD, Nelson MD, Wood JC. Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens. Magn Reson Med 2005;54:1185-1193.
9. Gossuin Y, Gillis P, Muller RN, Hocq A. Relaxation by clustered ferritin: a model for ferritin-induced relaxation in vivo. NMR Biomed 2007;20:749-756.
10. Gossuin Y, Muller RN, Gillis P, Bartel L. Relaxivities of human liver and spleen ferritin. Magn Reson Imaging 2005;23:1001-1004.
11. Gossuin Y, Muller RN, Gillis P. Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed 2004;17:427-432.
12. Gossuin Y, Burtea C, Monseux A, Toubeau G, Roch A, Muller RN, Gillis P. Ferritin-induced relaxation in tissues: an in vitro study. J Magn Reson Imaging 2004;20:690-696.
13. Wood JC, Fassler J, Meade T. Mimicking liver iron overload using liposomal ferritin preparations. Magn Reson Med 2004;51:607-611.
14. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J Magn Reson Imaging 2001;14:72-77.
15. Wood JC, Otto-Duessel M, Aguilar M, Nick H, Coates TD, Moats R. Dose response of deferoxamine, deferiprone, and ICL670 chelation therapy in a gerbil model of iron overload. Blood 2004;104:985a.
16. Wood JC, Otto-Duessel M, Gonzalez I, Aguilar MI, Shimada H, Nick H, Nelson M, Moats R. Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Transl Res 2006;148:272-280.
17. Wood JC, Otto-Duessel M, Aguilar M, Nick H, Nelson MD, Coates TD, Pollack H, Moats R. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535-543.
18. Hershko C, Link G, Konijn AM, Huerta M, Rosenmann E, Reinus C. The iron-loaded gerbil model revisited: effects of deferoxamine and deferiprone treatment. J Lab Clin Med 2002;139:50-58.
19. Obejero-Paz CA, Yang T, Dong WQ, Levy MN, Brittenham GM, Kuryshev YA, Brown AM. Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy. J Lab Clin Med 2003;141:121-130.
20. Yang T, Brittenham GM, Dong WQ, Levy MN, Obejero-Paz CA, Kuryshev YA, Brown AM. Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy. J Lab Clin Med 2003;142:332-340.
21. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000;343:327-331.
22. St Pierre TG, Clark PR, Chua-Anusorn W. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed 2004;17:446-458.
23. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-2059.
24. Guyader D, Gandon Y, Deugnier Y, Jouanolle H, Loreal O, Simon M, Bourel M, Carsin M, Brissot P. Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis. Gastroenterology 1989;97:737-743.
25. Hershko C, Konijn AM, Nick HP, Breuer W, Cabantchik ZI, Link G. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood 2001;97:1115-1122.
26. Ambu R, Crisponi G, Sciot R, Van Eyken P, Parodo G, Iannelli S, Marongiu F, Silvagni R, Nurchi V, Costa V. Uneven hepatic iron and phosphorus distribution in beta-thalassemia. J Hepatol 1995;23:544-549.
27. Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1996;25:172-177.
28. Ghugre NR, Enriquez CM, Gonzalez I, Nelson MD Jr, Coates TD, Wood JC. MRI detects myocardial iron in the human heart. Magn Reson Med 2006;56:681-686.